Gelteq Limited (GELS)
Nasdaq: GELS · Pharmaceutical Preparations · filing with the SEC since 2022
Income statement, as filed
In Australian dollars (AUD), as filed; per-share figures in Australian dollars; share counts. The fiscal year ends in June.| Fiscal year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Period ending | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 |
| Report filed | Nov 17, 2025 | Nov 15, 2024 | · |
| Revenue | 165,645 | · | 79,843 |
| Cost of revenue | 115,397 | · | · |
| Gross profit | 50,248 | · | · |
| Research and development | 628,606 | 276,057 | 665,035 |
| Operating income | -5,495,527 | -2,945,975 | -3,102,151 |
| Finance costs | 1,950,587 | 600,220 | 404,069 |
| Income before income taxes | -6,645,453 | -3,546,195 | -3,506,220 |
| Net income | -6,645,453 | -3,546,195 | -3,506,220 |
| Net income to shareholders | · | -3,546,195 | -3,506,220 |
| Earnings per share, basic | -0.72 | -0.44 | -0.44 |
| Earnings per share, diluted | -0.72 | -0.44 | -0.44 |
| Weighted average shares, basic | 9,272,375 | 8,118,075 | 7,940,026 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
ifrs-full:RevenueFromContractsWithCustomersCost of revenue what it cost to make or buy what it sold
ifrs-full:CostOfSalesGross profit revenue less the cost of what it sold
ifrs-full:GrossProfitResearch and development spent on inventing what it sells next
ifrs-full:ResearchAndDevelopmentExpenseOperating income profit from running the business, before interest and tax
ifrs-full:ProfitLossFromOperatingActivitiesFinance costs what its borrowing cost
ifrs-full:FinanceCostsIncome before income taxes profit before tax
ifrs-full:ProfitLossBeforeTaxNet income the whole group's profit, minority holders' share included
ifrs-full:ProfitLossNet income to shareholders the profit or loss that belongs to the company's shareholders
ifrs-full:ProfitLossAttributableToOwnersOfParentEarnings per share, basic net income per share outstanding
ifrs-full:BasicEarningsLossPerShareEarnings per share, diluted net income per share, counting every share that could be issued
ifrs-full:DilutedEarningsLossPerShareWeighted average shares, basic the average count of shares outstanding
ifrs-full:WeightedAverageShares